Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy
University of California, Los Angeles · UCLA Health · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
198
total citations
- FWCI
- 47.22
- Percentile
- 100%
- References
- 53
Citations per year
Authors
56Topics & keywords
Topics
Keywords
- CD8
- Immunotherapy
- T-cell receptor
- T cell
- Cytotoxic T cell
- Immunology
- Biology
- Human leukocyte antigen
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- MRMelanoma Research Alliance
- PIParker Institute for Cancer ImmunotherapyAward: R35 CA197633
- NINational Institutes of HealthAwards: T32 CA009120, P01 CA244118, CA197633, P30CA016042, R35 CA197633
- UOUniversity of California, Los AngelesAward: P30CA016042
- JCJonsson Comprehensive Cancer CenterAward: P30CA016042
- DGDavid Geffen School of Medicine, University of California, Los Angeles